Twist Bioscience Corp Stock
Price
Target price
€29.41
€29.41
5.530%
1.53
5.530%
€40.70
23.04.24 / Tradegate
WKN: A2N7L2 / Symbol: TWST / Name: Twist Bioscience / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Twist Bioscience Corp Stock
Twist Bioscience Corp dominated the market today, gaining €1.53 (5.530%).
Currently there is a rather positive sentiment for Twist Bioscience Corp with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 40 € shows a positive potential of 36.01% compared to the current price of 29.41 € for Twist Bioscience Corp.
Criterium "Revenue growth" is seen as the biggest plus for Twist Bioscience Corp stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Twist Bioscience Corp in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Twist Bioscience Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | 5.530% | 9.250% | -11.416% | 135.280% | -14.852% | -73.264% | - |
| Avid Bioservices Inc | 5.000% | -11.765% | -3.226% | -65.517% | -1.639% | -65.714% | 47.620% |
| Rockwell Medical Inc. | 1.620% | -4.810% | -3.193% | -26.923% | -20.034% | -85.152% | -96.854% |
| Gritstone Oncology Inc | 10.300% | -4.932% | -72.677% | -70.342% | -62.648% | -90.892% | - |
Comments
Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at Barclays PLC from $45.00 to $40.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Barclays PLC from $30.00 to $45.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $45.00 price target on the stock, up previously from $25.00.
Show more
Ratings data for TWST provided by MarketBeat
